{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:44:00Z","timestamp":1791859440009,"version":"4.3.4"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"14","license":[{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":807,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>We evaluated the relationship between adipokine plasma concentrations and body fat distribution and the metabolic syndrome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In a cohort of 1215 patients with clinically manifest vascular disease the relation between subcutaneous adipose tissue, visceral adipose tissue, waist circumference, body mass index and plasma concentrations of adipsin, chemerin, monocyte chemoattractant protein-1, migration inhibitory factor, nerve growth factor, resistin, plasma amyloid A1, adiponectin, leptin, plasminogen activator inhibitor-1 and hepatic growth factor were cross-sectionally assessed with linear regression and adjusted for age and gender. The relation between adipokines and the metabolic syndrome was cross-sectionally evaluated using logistic regression. An adipokine profile was developed to measure the effect of combined rather than single adipokines.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Adiposity was related to higher nerve growth factor, hepatic growth factor, migration inhibitory factor, leptin and adipsin and with lower chemerin, plasminogen activator inhibitor-1, resistin, plasma amyloid A1 and adiponectin. The strongest positive relations were between body mass index and adipsin (\u03b2 0.247; 95% CI 0.137\u20130.356) and leptin (\u03b2 0.266; 95% CI 0.207\u20130.324); the strongest negative relations were between body mass index and plasma amyloid A1 (\u03b2 \u20130.266; 95% CI \u20130.386 to \u20130.146) and visceral adipose tissue and adiponectin (\u03b2 \u20130.168; 95% CI \u20130.226 to \u20130.111). There was no relation between subcutaneous adipose tissue and adipokines. Odds for the metabolic syndrome were higher with each 1 SD higher hepatic growth factor (OR 1.21; 95% CI 1.06\u20131.38) and leptin (OR 1.26; 95% CI 1.10\u20131.45) and lower with each 1 SD higher adiponectin (OR 0.73; 95% CI 0.64\u20130.83) and resistin (OR 0.85; 95% CI 0.74\u20130.97). The adipokine profile was related to the metabolic syndrome (OR 1.03; 95% CI 1.00\u20131.06).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Plasma concentrations of adipokines are related to obesity and body fat distribution. The relation between adipokine concentrations and the metabolic syndrome is independent of visceral adipose tissue.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1177\/2047487318790722","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T12:48:55Z","timestamp":1532695735000},"page":"1548-1557","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":41,"title":["The relation between body fat distribution, plasma concentrations of adipokines and the metabolic syndrome in patients with clinically manifest vascular disease"],"prefix":"10.1093","volume":"25","author":[{"given":"Ilse M","family":"Schrover","sequence":"first","affiliation":[{"name":"Department of Vascular Medicine , University Medical Center Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"van der Graaf","sequence":"additional","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care , University Medical Center Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilko","family":"Spiering","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine , University Medical Center Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank LJ","family":"Visseren","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine , University Medical Center Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,29]]},"reference":[{"key":"2024062412582612900_bibr1-2047487318790722","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.106.675355","article-title":"Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study","volume":"116","author":"Fox","year":"2007","journal-title":"Circulation"},{"key":"2024062412582612900_bibr2-2047487318790722","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jacc.2017.07.763","article-title":"Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women","volume":"70","author":"Caleyachetty","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2024062412582612900_bibr3-2047487318790722","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2017.03.035","article-title":"Metabolically healthy obesity and the risk for subclinical atherosclerosis","volume":"262","author":"Kim","year":"2017","journal-title":"Atherosclerosis"},{"key":"2024062412582612900_bibr4-2047487318790722","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/ijo.2010.216","article-title":"Characterizing the profile of obese patients who are metabolically healthy","volume":"35","author":"Primeau","year":"2011","journal-title":"Int J Obes [Internet]"},{"key":"2024062412582612900_bibr5-2047487318790722","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/cen.12154","article-title":"Higher mortality in metabolically obese normal-weight people than in metabolically healthy obese subjects in elderly Koreans","volume":"79","author":"Choi","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024062412582612900_bibr6-2047487318790722","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/2047487317743355","article-title":"Cardiovascular disease predictors and adipose tissue macrophage polarization: Is there a link?","volume":"25","author":"Kralova Lesna","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"2024062412582612900_bibr7-2047487318790722","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/eurheartj\/ehn387","article-title":"Adipose tissue dysfunction in obesity, diabetes, and vascular diseases","volume":"29","author":"Hajer","year":"2008","journal-title":"Eur Heart J"},{"key":"2024062412582612900_bibr8-2047487318790722","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/01.CIR.0000115514.44135.A8","article-title":"Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women\u2019s Ischemia Syndrome Evaluation (WISE) Study","volume":"109","author":"Kip","year":"2004","journal-title":"Circulation"},{"key":"2024062412582612900_bibr9-2047487318790722","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jacc.2011.04.047","article-title":"Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals","volume":"58","author":"Voulgari","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2024062412582612900_bibr10-2047487318790722","doi-asserted-by":"crossref","first-page":"744","DOI":"10.2337\/dc06-1842","article-title":"Physical activity of moderate intensity and risk of type 2 diabetes: a systematic review","volume":"30","author":"Jeon","year":"2007","journal-title":"Diabetes Care"},{"key":"2024062412582612900_bibr11-2047487318790722","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2337\/dc06-1456","article-title":"Adiposity compared with physical inactivity and risk of type 2 diabetes in women","volume":"30","author":"Rana","year":"2007","journal-title":"Diabetes Care"},{"issue":"Pt 3","key":"2024062412582612900_bibr12-2047487318790722","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1042\/BST0360348","article-title":"Fatty acids and glucolipotoxicity in the pathogenesis of type 2 diabetes","volume":"36","author":"Cnop","year":"2008","journal-title":"Biochem Soc Trans [Internet]"},{"key":"2024062412582612900_bibr13-2047487318790722","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1017\/S0007114508894408","article-title":"Effect of the dietary fat quality on insulin sensitivity","volume":"100","author":"Galgani","year":"2008","journal-title":"Br J Nutr [Internet]"},{"key":"2024062412582612900_bibr14-2047487318790722","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2337\/db08-1739","article-title":"Type 2 diabetes risk alleles are associated with reduced size at birth","volume":"58","author":"Freathy","year":"2009","journal-title":"Diabetes"},{"key":"2024062412582612900_bibr15-2047487318790722","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2337\/db09-0117","article-title":"Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men","volume":"58","author":"Stan\u010d\u00e1kov\u00e1","year":"2009","journal-title":"Diabetes"},{"key":"2024062412582612900_bibr16-2047487318790722","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/01.CIR.103.4.513","article-title":"Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss","volume":"103","author":"Emdin","year":"2001","journal-title":"Circulation"},{"key":"2024062412582612900_bibr17-2047487318790722","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10059-012-0012-7","article-title":"Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: adipose depot specificity and gender dimorphism","volume":"33","author":"Alfadda","year":"2012","journal-title":"Mol Cells"},{"key":"2024062412582612900_bibr18-2047487318790722","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3346\/jkms.2011.26.6.797","article-title":"Association of serum retinol binding protein 4 with adiposity and pubertal development in Korean children and adolescents","volume":"26","author":"Rhie","year":"2011","journal-title":"J Korean Med Sci [Internet]"},{"key":"2024062412582612900_bibr19-2047487318790722","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1590\/S0066-782X2010005000109","article-title":"Body composition, biochemical and clinical changes of adolescents with excessive adiposity","volume":"95","author":"Serrano","year":"2010","journal-title":"Arq Bras Cardiol"},{"key":"2024062412582612900_bibr20-2047487318790722","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.atherosclerosis.2010.09.012","article-title":"Visceral adiposity and the severity of coronary artery disease in middle-aged subjects with normal waist circumference and its relation with lipocalin-2 and MCP-1","volume":"213","author":"Lee","year":"2010","journal-title":"Atherosclerosis"},{"key":"2024062412582612900_bibr21-2047487318790722","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4093\/dmj.2012.36.6.415","article-title":"Relation of absolute or relative adiposity to insulin resistance, retinol binding protein-4, leptin, and adiponectin in type 2 diabetes","volume":"36","author":"Kim","year":"2012","journal-title":"Diabetes Metab J"},{"key":"2024062412582612900_bibr22-2047487318790722","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1210\/jc.2006-2294","article-title":"Adiponectin independently predicts metabolic syndrome in overweight Latino youth","volume":"92","author":"Shaibi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2024062412582612900_bibr23-2047487318790722","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1177\/2047487317721655","article-title":"Relationship between neck circumference, insulin resistance and arterial stiffness in overweight and obese subjects","volume":"24","author":"Fantin","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"2024062412582612900_bibr24-2047487318790722","doi-asserted-by":"crossref","first-page":"E514","DOI":"10.1210\/jc.2012-3673","article-title":"Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome","volume":"98","author":"Jialal","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2024062412582612900_bibr25-2047487318790722","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/met.2008.0080","article-title":"Leptin, adiponectin, and high-sensitivity C-reactive protein in relation to the metabolic syndrome in urban South African blacks with and without coronary artery disease","volume":"7","author":"Ntyintyane","year":"2009","journal-title":"Metab Syndr Relat Disord"},{"key":"2024062412582612900_bibr26-2047487318790722","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/000331970605700302","article-title":"Increased serum leptin concentrations in patients with chronic stable angina pectoris and ST-elevated myocardial infarction","volume":"57","author":"Taneli","year":"2006","journal-title":"Angiology [Internet]"},{"key":"2024062412582612900_bibr27-2047487318790722","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/hrt.2003.011114","article-title":"Implications of plasma concentrations of adiponectin in patients with coronary artery disease","volume":"90","author":"Nakamura","year":"2004","journal-title":"Heart"},{"key":"2024062412582612900_bibr28-2047487318790722","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.atherosclerosis.2009.10.039","article-title":"Brain volumes and cerebrovascular lesions on MRI in patients with atherosclerotic disease. The SMART-MR study","volume":"210","author":"Geerlings","year":"2010","journal-title":"Atherosclerosis [Internet]"},{"key":"2024062412582612900_bibr29-2047487318790722","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1023\/A:1007621514757","article-title":"Second manifestations of ARTerial disease (SMART) study: rationale and design","volume":"15","author":"Simons","year":"1999","journal-title":"Eur J Epidemiol"},{"key":"2024062412582612900_bibr30-2047487318790722","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"key":"2024062412582612900_bibr31-2047487318790722","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/sj.ijo.0801734","article-title":"Validity and reproducibility of ultrasonography for the measurement of intra-abdominal adipose tissue","volume":"25","author":"Stolk","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2024062412582612900_bibr32-2047487318790722","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1373\/clinchem.2010.146118","article-title":"A multiplex immunoassay for human adipokine profiling","volume":"56","author":"Schipper","year":"2010","journal-title":"Clin Chem"},{"key":"2024062412582612900_bibr33-2047487318790722","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1210\/en.2007-0175","article-title":"Chemerin is a novel adipokine associated with obesity and metabolic syndrome","volume":"148","author":"Bozaoglu","year":"2007","journal-title":"Endocrinology"},{"key":"2024062412582612900_bibr34-2047487318790722","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.CIR.0000155620.10387.43","article-title":"Resistin is an inflammatory marker of atherosclerosis in humans","volume":"111","author":"Reilly","year":"2005","journal-title":"Circulation"},{"key":"2024062412582612900_bibr35-2047487318790722","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/oby.21674","article-title":"Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity","volume":"24","author":"Bekaert","year":"2016","journal-title":"Obesity"},{"key":"2024062412582612900_bibr36-2047487318790722","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.diabres.2008.08.001","article-title":"Inverse association between serum resistin and insulin resistance in humans","volume":"82","author":"Dom\u00ednguez Coello","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"2024062412582612900_bibr37-2047487318790722","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1210\/jc.2011-2310","article-title":"Relation of vascular growth factors with CT-derived measures of body fat distribution: the Framingham Heart Study","volume":"97","author":"Kaess","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2024062412582612900_bibr38-2047487318790722","doi-asserted-by":"crossref","first-page":"393142","DOI":"10.1155\/2013\/393192","article-title":"Adipose tissue dysfunction in nascent metabolic syndrome","volume":"2013","author":"Bremer","year":"2013","journal-title":"J Obesity"},{"key":"2024062412582612900_bibr39-2047487318790722","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1210\/jc.2008-0207","article-title":"Circulating ghrelin, leptin, and soluble leptin receptor concentrations and cardiometabolic risk factors in a community-based sample","volume":"93","author":"Ingelsson","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2024062412582612900_bibr40-2047487318790722","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00592-016-0885-6","article-title":"Lipid and inflammatory biomarker profiles in early insulin resistance","volume":"53","author":"Marcelino Rodr\u00edguez","year":"2016","journal-title":"Acta Diabetol [Internet]"},{"key":"2024062412582612900_bibr41-2047487318790722","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1210\/jc.2004-1588","article-title":"Strong association between serum hepatocyte growth factor and metabolic syndrome","volume":"90","author":"Hiratsuka","year":"2005","journal-title":"J Clin Endocrinol Metab [Internet]"},{"key":"2024062412582612900_bibr42-2047487318790722","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jacc.2006.09.053","article-title":"Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine","volume":"49","author":"Yl\u00e4-Herttuala","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2024062412582612900_bibr43-2047487318790722","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/sj.ijo.0803793","article-title":"Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity","volume":"32","author":"Hung","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"2024062412582612900_bibr44-2047487318790722","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12933-016-0339-z","article-title":"Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetes","volume":"15","author":"Ortega Moreno","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"2024062412582612900_bibr45-2047487318790722","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000453401","article-title":"rs1501299 Polymorphism in the adiponectin gene and their association with total adiponectin levels, insulin resistance and metabolic syndrome in obese subjects","volume":"69","author":"de Luis","year":"2016","journal-title":"Ann Nutr Metab [Internet]"},{"key":"2024062412582612900_bibr46-2047487318790722","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.atherosclerosis.2015.12.004","article-title":"Association between resistin levels and cardiovascular disease events in older adults: the Health, Aging and Body composition study","volume":"245","author":"Gencer","year":"2016","journal-title":"Atherosclerosis"},{"key":"2024062412582612900_bibr47-2047487318790722","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijcard.2008.11.017","article-title":"Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs","volume":"140","author":"Koh","year":"2010","journal-title":"Int J Cardiol"},{"key":"2024062412582612900_bibr48-2047487318790722","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/MCO.0000000000000317","article-title":"Lean, but not healthy: the \u201cmetabolically obese, normal-weight\u201d phenotype","volume":"19","author":"Ding","year":"2016","journal-title":"Curr Opin Clin Nutr Metab Care"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2047487318790722","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2047487318790722","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/25\/14\/1548\/58316972\/eurjpc1548.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/25\/14\/1548\/58316972\/eurjpc1548.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T13:02:35Z","timestamp":1719234155000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/25\/14\/1548\/5926331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":48,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2020,8,29]]},"published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1177\/2047487318790722","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,9,1]]},"published":{"date-parts":[[2018,9,1]]}}}